Henan Univ Chinese Med, Coconstruct Collaborat Innovat Ctr Chinese Med &, Henan & Educ Minist PR China, Zhengzhou 450046, Henan, Peoples R China
通讯作者
Li, Jiansheng
来源期刊
J Evid Based Med
ISSN
1756-5383
EISSN
1756-5383
出版日期
2021-12-01
卷号
14
期号
4
页码
333-345
摘要
Chinese medicine (CM) has significant clinical effects in the treatment of trachea-bronchitis. It is of important clinical significance to formulate guidelines for the diagnosis and treatment of tracheal-bronchitis based on the characteristics of TCM syndrome differentiation. The Respiratory Disease Branch of China Association of Chinese Medicine and Respiratory Disease Branch of China Medical Association of Minorities have organized and established a multidisciplinary working group, based on the World Health Organization Handbook for Guideline Development and the Guideline Development Handbook for Diagnosis and Therapy of Integrative Medicine to develop this guideline. It has been developed through technical links such as clinical problem investigation, evidence collection and evaluation, Delphi method, and expert consensus meetings. Based on the current best evidence, CM intervention costs and expert experience, 25 recommendations were established to standardize the etiology and pathogenesis of tracheal-bronchitis, syndrome differentiation and treatment, prevention, and care, etc., which can be used by respiratory physicians at all levels of TCM medical institutions.
National Special Support Program for High-level Talent ("Ten Thousand Talents Program") Leading Talent (W02060076), Chief Scientist of Qihuang Scholars Award of the State TCM Academic Leader Program and Central Plains Thousand People Program (No. ZYQR202107).
